Funding Rounds
NorthSea Therapeutics Series B (2020, $39M)
NorthSea TherapeuticsInnovative therapeutic drugs to treat inflammatory, metabolic and liver diseases.
Summary
Stage: Series B
Raised Amount: $39.99M
Raised Date: 2020-01-01
Stage: Series B
Raised Amount: $39.99M
Raised Date: 2020-01-01
